Bayer Global Investments B.v. - Net Worth and Insider Trading
Bayer Global Investments B.v. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bayer Global Investments B.v. owns 1 companies in total, including CRISPR Therapeutics AG (CRSP) .
Click here to see the complete history of Bayer Global Investments B.v.’s form 4 insider trades.
Insider Ownership Summary of Bayer Global Investments B.v.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2018-01-05 | 10 percent owner |
Bayer Global Investments B.v. Trading Performance
Bayer Global Investments B.v. Ownership Network
Bayer Global Investments B.v. Owned Company Details
What does CRISPR Therapeutics AG do?
Who are the key executives at CRISPR Therapeutics AG?
Bayer Global Investments B.v. is the 10 percent owner of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Business Officer Samarth Kulkarni , Chief Financial Officer Raju Prasad , and General Counsel and Secretary James R. Kasinger .
CRISPR Therapeutics AG (CRSP) Insider Trades Summary
Over the past 18 months, Bayer Global Investments B.v. made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 225,337 shares made by Samarth Kulkarni , a net sale of 5,860 shares made by James R. Kasinger , and a net sale of 3,524 shares made by Raju Prasad .
In summary, during the past 3 months, insiders sold 0 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,087 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 238,087 shares.
CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CRISPR Therapeutics AG Insider Transactions
Bayer Global Investments B.v. Mailing Address
Above is the net worth, insider trading, and ownership report for Bayer Global Investments B.v.. You might contact Bayer Global Investments B.v. via mailing address: C/o Crispr Therapeutics Ag, 200 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
